"Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease ..."

Vijay Kumar Bhardwaj et al. (2021)

> Home

Details and statistics

DOI: 10.1016/J.COMPBIOMED.2020.104117

access: closed

type: Journal Article

metadata version: 2024-10-06

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/cbm/BhardwajSDP21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cbm/BhardwajSDP21
Vijay Kumar Bhardwaj, Rahul Singh, Pralay Das, Rituraj Purohit:
Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs. Comput. Biol. Medicine 128: 104117 (2021)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.